Jelena D. Milosevic Feenstra
Medical University of Vienna(AT)
Publications by Year
Research Areas
Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Eosinophilic Disorders and Syndromes, SARS-CoV-2 and COVID-19 Research
Most-Cited Works
- → Somatic Mutations of Calreticulin in Myeloproliferative Neoplasms(2013)1,952 cited
- → JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes(2013)576 cited
- → Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms(2015)272 cited
- → Loss of Ezh2 synergizes with JAK2 -V617F in initiating myeloproliferative neoplasms and promoting myelofibrosis(2016)114 cited
- → Chromothripsis in acute myeloid leukemia: biological features and impact on survival(2018)112 cited
- → Frequent deletions of JARID2 in leukemic transformation of chronic myeloid malignancies(2011)104 cited
- → Clinical significance of genetic aberrations in secondary acute myeloid leukemia(2012)79 cited
- → Genetic and epigenetic alterations of myeloproliferative disorders(2012)76 cited
- → CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis(2014)71 cited
- → Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms(2019)71 cited